Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dayamitra Telekomunikasi Tbk. (MTEL) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance

Dayamitra Telekomunikasi Tbk.Trade
Organon Pharma Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Dayamitra Telekomunikasi Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Dayamitra Telekomunikasi Tbk. trades at Rp478 (market cap 41.28T, 42.08M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Dayamitra Telekomunikasi Tbk. is far larger — about 395.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

MTELSCPI
Market Cap
41.28T104.4B
Volume
42.08M
Lot
420.83K
Turnover
20.18B
Average Price
479.6
Value
20.18B
Indicative Equilibrium Price
478
Indicative Equilibrium Volume
102.89K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MTEL
View details
SCPI
View details

About Dayamitra Telekomunikasi Tbk.

PT Dayamitra Telekomunikasi Tbk. (the Company), previously known as PT Dayamitra Malindo, was established on October 18, 1995 in the framework of the Republic of Indonesia Foreign Investment Law No. 1 of 1967, as amended by Law No. 11 of 1970, with the approval of the President of the Republic of Indonesia in Decree No.B-576/ Pres/10/1995 dated October 16, 1995. The Company changed its name from PT Dayamitra Malindo to PT Dayamitra Telekomunikasi Tbk. by Notarial Deed from Hendra Karyadi, S.H., No. 53 dated August 28, 1997. Furthermore, based on the Decree of theHead of the Investment Coordinating Board No. 244/T/Perhubungan/2006 dated March 22, 2006, the change of the Company's status as foreign investment has changed to domestic.

Read more on MTEL

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI